Chase Investment Counsel Corp Emergent Bio Solutions Inc. Transaction History

Chase Investment Counsel Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$79.17 - $111.47 $187,632 - $264,183	-2,370 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$81.91 - $134.94 $194,126 - $319,807	2,370 New	2,370 $244,000
Q1 2019 May 03, 2019	SELL	$48.23 - $66.16 $1.06 Million - $1.46 Million	-22,032 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$55.63 - $73.24 $256,899 - $338,222	4,618 Added 26.52%	22,032 $1.31 Million
Q3 2018 Nov 01, 2018	BUY	$52.05 - $66.51 $906,398 - $1.16 Million	17,414 New	17,414 $1.15 Million

158

32.6M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $429M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.